Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance ima…
| Periodo | 2026-11 | 2026-07 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $0.56 | $0.27 | $0.71 |
| Estimado | $0.36 | $0.37 | $0.19 | $0.50 |
| Sorpresa | — | +51.4% | +42.1% | +42.0% |
| Métrica | PHG | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 45.2% | 57.4% | -12.2% |
| Operating Margin | 8.0% | -34.4% | +42.4% |
| Net Margin | 5.0% | -32.5% | +37.5% |
| FCF Margin | — | -12.6% | — |
| ROE | 8.2% | -39.2% | +47.3% |
| ROA | 3.3% | -30.9% | +34.3% |
| Current Ratio | 1.32 | 2.73 | -1.41 |
| Debt / Equity | 0.63 | 0.28 | +0.35 |
| Tendencia (Piotroski) | FY25 | FY24 |
|---|---|---|
| ✓Rentabilidad sobre activos positiva | 3.3% | — |
| ✗Flujo de caja operativo positivo | — | — |
| ✓Rentabilidad sobre activos al alza | 3.3% | -2.4% |
| –Caja operativa/activos supera al ROA | — | ROA 3.3% |
| ✗Menos deuda a largo plazo | 25.7% | 24.5% |
| ✓Mejor liquidez (ratio corriente) | 1.32 | 1.23 |
| ✗Sin aumentar el nº de acciones | 963M | 933M |
| ✓Margen bruto al alza | 45.2% | 43.1% |
| ✓Rotación de activos al alza | 0.66 | 0.62 |
| Calidad del negocio | FY25 |
|---|---|
| ✗ROCE > 10 % | 7.3% |
| ✗Ventas > 5 %/año (3 años) | 0.0% |
| ✓Deuda neta/EBITDA < 3x | 2.1x |
| ✓Reinversión (I+D + capex) > 3 % de ventas | 11.0% |
KONINKLIJKE PHILIPS NV cotiza a 25.74 USD y tiene una capitalización bursátil de $25.2B. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud